Revenue: | |
Product revenue | |
Research and development revenue | 4.45M |
Total revenues | 4.45M |
Operating expenses: | |
Cost of goods sold | |
Research and development | -21.59M |
General and administrative | -8.11M |
Operating loss | -36.22M |
Other income (expense): | |
Non-operating income (expense) | -139.64K |
Interest expense | |
Interest income | |
Net loss | -40.77M |
Dividends on series A convertible preferred stock | |
Net loss attributable to common stockholders | -40.82M |
Per common share data, basic and diluted: | |
Net loss attributable to common stockholders | |
Weighted average number of common shares outstanding, basic and diluted |